JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitamura, H.
Right arrow Articles by Yamada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitamura, H.
Right arrow Articles by Yamada, M.
Right arrowPubmed/NCBI databases
*Protein
*Compound via MeSH
*Substance via MeSH

Vol. 293, Issue 1, 196-205, April 2000


Tertiapin Potently and Selectively Blocks Muscarinic K+ Channels in Rabbit Cardiac Myocytes1

Hidetsuna Kitamura , Mitsuhiro Yokoyama, Hozuka Akita, Kenji Matsushita, Yoshihisa Kurachi and Mitsuhiko Yamada

Department of Cardiac Physiology, National Cardiovascular Center Research Institute, Suita, Osaka, Japan (H.K., M.Ya.); First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan (H.K., M.Yo., H.A.); and Department of Pharmacology II, Faculty of Medicine, Osaka University, Osaka, Japan (K.M., Y.K.)

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Tertiapin is a 21-residue peptide isolated from honey bee venoms. A recent study indicated that tertiapin is a potent blocker of certain types of inwardly rectifying K+ (Kir) channels (Jin and Lu, 1998). We examined the effect of tertiapin on ion channel currents in rabbit cardiac myocytes using the patch-clamp technique. In the whole-cell configuration, tertiapin fully inhibited acetylcholine (1 µM)-induced muscarinic K+ (KACh) channel currents in atrial myocytes with the half-maximum inhibitory concentration of ~8 nM through ~1:1 stoichiometry. The potency of tertiapin in inhibiting KACh channels was not significantly different at -40 and -100 mV. Tertiapin also inhibited the KACh channel preactivated by intracellular guanosine 5'-O-(3-thiotriphosphate), a nonhydrolyzable GTP analog. A constitutively active Kir channel, the IK1 channel, was at least 100 times less sensitive to tertiapin. Another Kir channel in cardiac myocytes, the ATP-sensitive K+ channel, was virtually insensitive to tertiapin (1 µM). The voltage-dependent K+ and the L-type Ca2+ channels were not affected by tertiapin (1 µM). At the single-channel level, tertiapin inhibited the KACh channel from the outside of the membrane by reducing the NPo (N is the number of functional channels, and the Po is the open probability of each channel) without affecting the single-channel conductance or fast kinetics. Therefore, tertiapin potently and selectively blocks the KACh channel in cardiac myocytes in a receptor- and voltage-independent manner. Tertiapin is a novel pharmacological tool to identify the functional role of the KACh channel in the parasympathetic regulation of the heart beat.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Tertiapin is a peptide composed of 21 amino acids (Fig. 1) that was initially isolated from venoms of the European honey bee, Apis mellifera, more than 20 years ago (Gauldie et al., 1976). This peptide has six positively charged residues in a molecule, four of which are clustered within the C-terminal half of the polypeptide chain. Tertiapin completely lacks negatively charged residues, and the lysine at the carboxyl end is in an amide form. Four cysteines in the peptide form two disulfide bonds. NMR spectroscopy revealed that tertiapin has a type-I reverse turn and an alpha -helix, which are connected by a loop of an extended beta -sheet (Xu and Nelson, 1993). The three-dimensional structure of tertiapin is highly compact due to extensive side chain interaction. Different from other bee peptidyl toxins, such as apamin and mast cell-degranulating peptide, the biological target of tertiapin had not been known until Jin and Lu (1998) found that tertiapin potently blocks certain types of recombinant inwardly rectifying K+ (Kir) channels. Although there are many known peptidyl toxins blocking the voltage-dependent K+ channels (Adams and Swanson, 1996), tertiapin is the sole potent Kir channel blocker identified so far.


View larger version (5K):
[in this window]
[in a new window]
 
Fig. 1.   Amino acid sequence of tertiapin. The amino acid sequence of tertiapin is indicated with the single-letter code. The lines connecting cysteines represent the disulfide bond arrangement.

Kir channels are highly K+-selective ion channels that carry K+ ions from extracellular to intracellular space more efficiently than in the other direction (Nichols and Lopatin, 1997). This inwardly rectifying property allows the channels to fix the cell resting membrane potential toward the K+ equilibrium potential (EK) (~-85 mV under physiological condition) without preventing action potential generation (Hille, 1992). There are multiple distinct types of Kir channels that differ in the extent of inward rectification. Some of them completely shut outward K+ currents at the membrane potential more positive than EK +60 mV (strong inward rectifiers), whereas others permit large outward currents even at EK +200 mV (weak inward rectifiers). Kir channels are also diverse in the regulation of activity. Some Kir channels are constitutively active, but others are regulated by various intracellular signaling molecules, such as G proteins, nucleotides, protein kinase/phosphatase, and anchoring proteins (Yamada et al., 1998).

Kir channels play a particularly important role in such a cell type as cardiac myocytes, where the resting potential is ~EK, whereas the action potential duration is as long as several hundred milliseconds. Cardiac myocytes possess three distinct types of Kir channels (Isomoto et al., 1997). The IK1 channel is a constitutively active, strong inward rectifier and determines the basic electrophysiological property of working ventricular myocytes and some atrial myocytes. Nodal, atrial, and Purkinje myocytes have another inward rectifier, muscarinic K+ (KACh) channel, whose inward rectification is slightly weaker than that of the IK1 channel (Yamada et al., 1998). KACh channels have a low basal activity and are activated by acetylcholine (ACh), adenosine, and sphingosine-1-phosphate. Receptors recognizing these substances activate the pertussis toxin-sensitive heterotrimeric G protein, which in turn directly activates the channels through its beta gamma -subunit. This signaling pathway mediates the negative chronotropic and dromotropic effects caused by the substances. The third Kir channel is a weak inward rectifier, the ATP-sensitive K+ (KATP) channel (Terzic et al., 1995). This channel is completely inhibited by millimolar concentrations of intracellular ATP in normal cardiac myocytes. When the ATP level decreases on ischemia, the channel is activated and evokes K+ currents, which markedly shorten the action potential duration to attenuate contraction.

Differential expression and regulation of these Kir channels in cardiac myocytes are fundamental requirements for the physiological heart beat. However, the lack of specific blockers of these channels has impeded the direct demonstration of the role of the IK1 and KACh channels in the cardiac physiology. Thus, we examined the effect of tertiapin on ion channel currents in cardiac myocytes. We show here that tertiapin potently and selectively blocks KACh channels. Tertiapin is, therefore, a useful pharmacological tool to identify the functional role of KACh channels in the cardiac physiology and pathophysiology.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Cell Isolation. Male Japanese-White rabbits weighing 1.5 to 2.5 kg were treated with heparin sodium (200 U/kg b.wt.) injected via an ear vein. Approximately 20 min later, the rabbits were anesthetized with pentobarbital sodium (30 mg/kg b.wt.) applied through a vein in another ear. As soon as rabbits completely lost a nociceptive response, the heart was quickly removed and mounted on the Langendorff apparatus. The heart was immediately reperfused with the oxygenated control bathing solution (for composition, see later) through coronary arteries at 37°C. When the heart exhibited a stable sinus rhythm, the solution was switched to the oxygenated nominally Ca2+-free Tyrode's solution (for composition, see later). When the heart completely ceased contraction, the solution was exchanged to the same solution containing 0.04% (w/w) collagenase. After 5 to 10 min of digestion, the heart was perfused with 60 ml of KB solution (for composition, see later) and stored in the fresh KB solution at 4°C until use.

Electrophysiological Measurement. A small piece of tissue was excised from the digested myocardium with fine scissors and gently shaken in the control bathing solution in an experimental chamber mounted on the stage of a vertical microscope (Axiovert S100; Carl Zeiss, Jana, Germany). When myocytes dissociated from the shaken tissue stuck to the glass bottom of the chamber, the control bathing solution was perfused through a gravity-feeding apparatus connected to the chamber.

Cell membrane currents were measured from myocytes with smooth surface and clear striations by the patch-clamp method (Hamill et al., 1981) with a patch-clamp amplifier (Axopatch 200B; Axon Instruments Inc., Foster City, CA). The patch pipette was fabricated from 1.8-mm-o.d. glass capillary tubes (Kimax-51; Kimble) with a vertical puller (PP-830; Narishige, Tokyo, Japan). The tapered region of the pipette was coated with Sylgard (Dow Corning, Midland, MI). After fire polishing of the tip with a microforge (MF-830; Narishige), pipettes had the resistance of 1 to 3 MOmega in the control bathing solution when filled with the internal solution or the K+ external solution (for compositions, see later). After the liquid junction potential was electrically removed, the giga-ohm seal was formed with continuously applied 10-ms voltage steps from 0 to +10 mV at 16 Hz under the voltage-clamp condition.

For the whole-cell configuration, the pipette was filled with the internal solution containing 3 mM ATP and 100 µM GTP unless otherwise indicated. After formation of the giga-ohm seal, the pipette potential was switched to -40 mV, and the patch membrane was ruptured with gentle suction applied to the pipette. The cell capacitative current was electrically removed with the amplifier. The series resistance was 3.9 ± 0.2 MOmega (mean ± S.E., n = 73) and routinely compensated by 90%. Whole-cell membrane currents were measured at the gain of 0.5 to 2 mV/pA. The voltage command pulses were applied to the amplifier through its external command input from a data acquisition board (AT-MIO-16X; National Instruments, Austin, TX) equipped on a personal computer (GP5-200; Gateway 2000, N. Sioux City, SD). This board was driven by a homemade program written with LabVIEW for Windows (National Instruments, Austin, TX).

In the cell-attached and the inside-out configurations, pipettes were filled with the K+ external solution, and the chamber was perfused with the internal solution. For the outside-out configuration, the pipette solution was the same as in the whole-cell configuration, whereas the outside of the patch membrane was perfused with the K+ external solution. In single-channel recordings, the gain of the amplifier was set at 100 mV/pA.

Throughout experiments, the current and voltage outputs of the amplifier were continuously monitored with a digital oscilloscope (DCS-720; Kenwood, Tokyo, Japan) and recorded on a paper with an analog thermal array recorder (RTA-1100; Nihon Kohden, Tokyo, Japan) after low-pass filtering at 2 kHz (-3 dB) with a four-pole Bessel filter (multifunction filter 3611; NF Electronic Instruments, Yokohama, Japan). For off-line analyses, the data were filtered at 10 kHz, sampled at 47.2 kHz by the PCM recorder (VR10B; Instrutech Co., Long Island, NY), and stored on a video cassette tape by a video cassette recorder (SLV-675HF; Sony, Tokyo, Japan). These data were subsequently reproduced by the same PCM recorder, filtered at 1 to 2 kHz, digitized at 3 to 5 kHz with an AD converter (ITC-16i; Instrutech Co., Long Island, NY), and then analyzed with another computer (Power Macintosh G3; Apple, Cupertino, CA) and commercially available software (Patch Analyst Pro; MT Corporation, Hyogo, Japan). For spectral analysis of single-channel current fluctuations, the reproduced data were filtered at 5 kHz (-3 dB) with a Butterworth filter and digitized at 12.5 kHz. The data were divided into short segments of 8192 points and were multiplied point by point by a Blackman Harris window function and then Fourier transformed. Power density spectrum was constructed, subtracted from that in the absence of channel openings, and fit with the following sum of Lorentzian functions:
S(x)= <LIM><OP>∑</OP><LL>i</LL><UL>n</UL></LIM> <FR><NU>S<SUB>i</SUB></NU><DE>1+<FENCE><FR><NU>x</NU><DE>F<SUB>i</SUB></DE></FR></FENCE><SUP>2</SUP></DE></FR> (1)
where S(x) is the power spectral density at the frequency of x, Si is the zero-frequency asymptote, and Fi is the corner frequency of ith Lorentzian component.

All statistical values are indicated as mean ± S.E. The statistical difference was evaluated by Student's paired (Fig. 5) or unpaired (otherwise) t test. Statistical probability of P < .05 was taken as a significant difference.

Solutions. The control bathing solution contained 136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.5 mM HEPES (pH adjusted to 7.4 with NaOH). Nominally Ca2+-free Tyrode's solution was the same in composition as the control bathing solution except that no CaCl2 was added. The KB solution contained 10 mM taurine, 10 mM oxalic acid, 70 mM glutamic acid, 25 mM KCl, 10 mM KH2PO4, 11 mM glucose, 0.5 mM EGTA, and 10 mM HEPES (pH adjusted to 7.3 with KOH). The internal solution contained 140 mM KCl, 2 mM MgCl2, 5 mM EGTA, and 5 mM HEPES (pH adjusted to 7.4 with KOH). The concentration of free Mg2+ in this solution was calculated to be 1.4 mM. When nucleotides such as ATP and GTP were added to the internal solution, MgCl2 was supplemented to maintain the free Mg2+ concentration. The K+ external solution contained 140 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES (pH adjusted to 7.4 with KOH).

According to the manufacturer's recommendation, tertiapin was dissolved in distilled water at 100 µM, dispensed into small aliquots in polypropylene tubes, and stored at -20°C until use. Immediately before use, the peptide was diluted to the desired concentration in vehicles in polypropylene tubes. ACh and guanosine 5'-O-(3-thiotriphosphate) (GTPgamma S) were dissolved at 10 mM and 100 µM, respectively, in distilled water and stored at -20°C as small aliquots until use. ATP and GTP were prepared daily from powder and stored at 4°C until use.

Chemicals. Tertiapin was a kind gift from Peptide Institute Inc. (Osaka, Japan). Acetylcholine chloride, ATP (dipotassium salt), and GTPgamma S were purchased from Sigma Chemical Co. (St. Louis, MO). Pentobarbital sodium was obtained from Dainippon Pharmaceutical Co. Ltd. (Osaka, Japan). Heparin sodium was obtained from Aventis (Frankfurt, Germany). Collagenase was obtained from Yakult (Tokyo, Japan). GTP and all other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan).

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effect of Tertiapin on Ion Channel Currents in Rabbit Atrial Myocytes. We measured membrane currents from a rabbit atrial myocyte in the whole-cell configuration (Fig. 2A). From the holding potential of -40 mV, 500-ms voltage pulses between -100 and +40 mV were applied to the cell in a 10-mV increment every 5 s. In the control condition (a), the hyperpolarizing voltage steps to potentials more negative than -70 mV elicited inward IK1 currents (Sakmann and Trube, 1984; Kurachi, 1985). The currents were promptly activated and then slightly decreased. On repolarization to -40 mV, a large inward Na+ current was evoked (Brown et al., 1981). When the membrane was depolarized to the potentials more positive than -40 mV, the slow inward Ca2+ (ICa) current appeared (McDonald et al., 1994), which was followed by gradually developing outward voltage-dependent K+ (IK) currents (Sanguinetti and Jurkiewicz, 1990). Repolarization to -40 mV from these potentials elicited the outward IK tail currents. The current-voltage (I-V) relationships measured at the beginning and the end of each step are shown in Fig. 2B (closed and open circles, respectively). At potentials negative to -40 mV, both the I-V curves inwardly rectified due to the IK1 currents. At potentials positive to -40 mV, the instantaneous I-V curve exhibited the U shape with a peak at 0 mV reflecting the inward L-type ICa current. On the other hand, the steady-state I-V curve gradually increased in the positive direction as the membrane potential was depolarized. This was due to the IK currents.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of tertiapin on ion channel currents in a rabbit atrial myocyte. A, in the whole-cell configuration, membrane currents were measured from a rabbit atrial myocyte under the control condition (a), 80 s after the application of ACh (1 µM) (b), 60 s after the application of ACh plus tertiapin (100 nM) (c), and 73 s after the washout of ACh (d). The pipette was filled with internal solution containing 3 mM ATP and 100 µM GTP. Under each condition, 500-ms voltage pulses between -100 and +40 mV were applied from -40 mV in 10-mV increments every 5 s. Arrowheads and dotted lines indicate the zero current level. A leak and capacitative currents were not subtracted. B, I-V relationship measured from the experiment in A. Filled and open symbols indicate the current amplitudes at the beginning and end of each voltage step, respectively.

When ACh (1 µM) was applied, voltage steps negative to -80 mV elicited slowly developing large inward currents (Fig. 2A, b). These are Ach-induced KACh currents (Yamada et al., 1998). On repolarization to -40 mV, large outward tail currents appeared due to the slow deactivation of the currents. The steady-state I-V curve (Fig. 2B, open squares) exhibited inward rectification and crossed the control steady-state I-V curve at ~-80 mV. At potentials more negative than -40 mV, the absolute amplitudes of the steady-state currents (open squares) were always larger than those of the instantaneous currents (closed squares) because of the relaxation of KACh currents. At potentials positive to -40 mV, ACh caused a roughly parallel shift of the control instantaneous and steady-state I-V curves in the positive direction, suggesting that ACh did not significantly affect the ICa or IK currents.

Tertiapin (100 nM) applied in the presence of ACh almost completely abolished the KACh currents (Fig. 2, A, c, and B, triangles). When ACh was washed out in the presence of tertiapin, inward currents at potentials negative to -80 mV slightly decreased (Fig. 2A, d), indicating that tertiapin (100 nM) did not completely inhibit KACh channels. The I-V relationships in the presence of tertiapin alone (Fig. 2B, inverted triangles) were almost identical to those under the control condition (circles), except that the current amplitude at -100 mV was slightly smaller with tertiapin. Therefore, tertiapin (100 nM) almost completely inhibited KACh currents and only slightly inhibited IK1 currents without significantly affecting other channel currents.

Effect of Tertiapin on KATP Channels in Rabbit Ventricular Myocytes. Figure 3 depicts the effect of tertiapin on another Kir channel in cardiac myocyte, the KATP channel. These traces were recorded from a ventricular myocyte. In the ventricular myocyte, there was a much larger IK1 current than in atrial myocytes (cf. Fig. 2A, a). Under the control condition, the steady-state I-V curve (Fig. 3B, open circles) was in an N shape due to the strong inward rectification of IK1 channels (Kurachi, 1985). Pinacidil (100 µM), an activator of KATP channels, induced large time-independent outward currents at potentials more positive than -70 mV (Fig. 3A, b) (Terzic et al., 1995). However, inward currents at potentials negative to -80 mV did not increase as prominently; this is because the inward rectification of KATP channels is so weak that the current exhibits even a slightly outward rectification in the presence of 5.4 mM extracellular K+ as expected from the constant field theory (Findlay, 1987). Therefore, the inward rectification of the steady-state I-V relationship became weaker after the application of pinacidil than the control (Fig. 3B, open squares). The ICa currents (roughly estimated as a difference between the instantaneous and the steady-state currents at >= -30 mV) became smaller after the application of pinacidil. This was probably due to the rundown of ICa channels (McDonald et al., 1994). Tertiapin (1 µM) did not significantly inhibit the pinacidil-induced currents (Fig. 3A, c, and B, triangles), whereas glibenclamide (1 µM), a specific inhibitor of KATP channels, strongly suppressed the KATP currents (Fig. 3A, d) (Terzic et al., 1995). Under this condition, the steady-state currents (Fig. 3B, open inverted triangles) at potentials negative to -80 mV were slightly smaller than those under the control condition. This is probably because of the weak inhibitory effect of tertiapin on IK1 channel currents. In summary, tertiapin (1 µM) did not significantly inhibit KATP channels. This observation was confirmed in two additional experiments with different ventricular myocytes (not shown).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of tertiapin on KATP channel in a rabbit ventricular myocyte. A, whole-cell currents recorded from a rabbit ventricular myocyte under the control condition (a), 171 s after the application of pinacidil (100 µM) (b), 74 s after the application of pinacidil and tertiapin (1 µM) (c), and 148 s after the application of pinacidil, tertiapin, and glibenclamide (1 µM) (d). The same voltage pulses as in Fig. 2 were applied to the cell. A leak and capacitative currents were not subtracted. B, I-V relationship measured in A. Filled and open symbols indicate the current amplitudes at the beginning and the end of each voltage step, respectively.

Concentration-Dependent Inhibition of KACh and IK1 Channels by Tertiapin. We next examined the concentration-dependent effect of tertiapin on KACh and IK1 channels (Fig. 4). The upper row in Fig. 4A depicts a continuous recording of the whole-cell current of an atrial myocyte. Throughout the experiment, three consecutive voltage steps to -100, -40, and +10 mV were applied from the holding potential of -40 mV every 3 s (left bottom corner of Fig. 4A). The duration of each the step was 300 ms. The thick lines above the current trace indicate the perfusion protocol, according to which the experiment was divided into four parts (indicated by thin lines 1-4).


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 4.   Experimental protocol to assess the concentration-dependent effect of tertiapin on KACh currents. A, top row shows a record of whole-cell currents of a rabbit atrial myocyte. Thick lines above the trace indicate the bath perfusion protocol, according to which the experiment is divided into four parts (indicated by thin lines 1-4). Throughout the experiment, the voltage pulse drawn at the bottom left corner was applied from -40 mV every 3 s. In this pulse protocol, the membrane potential was first hyperpolarized to -100 mV and then depolarized to -40 and finally to +10 mV. Each step was 300 ms in duration. An inward Na+ current is eliminated from the trace in the top row. Open and closed circles indicate the current amplitudes at the end of the steps to -40 and -100 mV, respectively. The time-dependent decrease in these current amplitudes in part 2 was fit by eqs. 2 and 3, respectively. The curves were extended to the end of part 3 and shown as lines f and g. Bottom row, fast speed records of the currents within the single set of voltage pulses applied at times a-e indicated in the top row. The Na+ current is not eliminated in these traces. B, the amplitudes of the ACh-induced currents at -40 (open circle ) and -100 mV () in parts 2 and 3 were normalized to those predicted from the lines f and g and plotted against time after the application of ACh (see eqs. 4-7). Two horizontal lines in the graph (designated as -40 and -100 mV) indicate the mean of the normalized currents between 95 and 135 s, which were 0.64 and 0.60, respectively. C, comparison of waveforms of KACh currents in the presence and absence of tertiapin. Trace c - a was produced by subtraction of trace a from trace c, corresponding to the Ach-induced KACh current shortly before the application of tertiapin. Line g predicts that the current at time c would have decreased to 77% at time d if tertiapin had not been applied. Thus, the Ach-induced KACh current at time d in the absence of tertiapin is shown as trace 0.77c - a. B, this current is further decreased to 64% in the presence of tertiapin, which is shown as trace 0.64(0.77c - a) (dotted line). The real Ach-induced KACh current at time d in the presence of tertiapin was obtained by subtraction of trace e from trace d (trace d - e, solid line).

In part 1, no drugs were applied. Channel currents recorded within the single set of voltage pulses at time a are shown in a faster time scale as trace a in the lower row. The first command step to -100 mV elicited an inward IK1 current; the second step to -40 mV, a large transient inward Na+ current; and the final step to +10 mV, a slow inward ICa current followed by an outward IK current. Open and closed circles in the trace (and in all other traces in this figure) indicate the quasi-steady-state amplitude of the currents at -40 and -100 mV, respectively [I(t)-40 and I(t)-100, where t is the time after the application of ACh in s]. The average values of I(t)-40 and I(t)-100 in part 1 (mI-40(1) and mI-100(1)) were 3.97 and -103.47 pA, respectively.

The application of ACh (1 µM) suddenly activated KACh channels and increased the currents in the positive direction at -40 and +10 mV and in the negative direction at -100 mV (part 2 and trace b). The currents gradually decreased due to the short-term desensitization of KACh channels (part 2 and trace c). The decay of I(t)-40 and I(t)-100 in part 2 was fit by the following biexponential functions:
f<SUB><UP>−</UP>40</SUB>(t)=224+421 <UP>exp</UP>(<UP>−</UP>t/2.9)+203 <UP>exp</UP>(<UP>−</UP>t/150) (2)

f<SUB><UP>−</UP>100</SUB>(t)=<UP>−</UP>515−1095 <UP>exp</UP>(<UP>−</UP>t/3.6)−1183 <UP>exp</UP>(<UP>−</UP>t/165) (3)
where f-40(t) and f-100(t) are in pA. These curves were extended to the end of part 3 and represented as lines f and g, respectively. The curves predict how KACh currents would have decreased spontaneously if tertiapin had not been applied. Tertiapin (10 nM) applied in the middle of the desensitization reduced the KACh currents much faster than expected from the curves (part 3 and trace d).

When ACh was washed out in the presence of tertiapin (part 4), the remaining currents quickly decreased due to the prompt deactivation of KACh channels (see also trace e). The averaged values of I-40(t) and I-100(t) in part 4 [mI-40(4) and mI-100(4)] were -6.25 and -96.56 pA, respectively.

To quantitatively estimate the effect of tertiapin on KACh currents, ACh-induced currents in parts 2 and 3 were normalized to those predicted by eqs. 2 and 3. This was done by the following calculations:

In part 2, 
<UP>nI</UP>(t)<SUB><UP>−</UP>40</SUB>=[<UP>I</UP>(t)<SUB><UP>−</UP>40</SUB>−<UP>mI</UP><SUB><UP>−</UP>40(1)</SUB>]/[f<SUB><UP>−</UP>40</SUB>(<UP>t</UP>)−<UP>mI</UP><SUB><UP>−</UP>40(1)</SUB>] (4)

<UP>nI</UP>(t)<SUB><UP>−</UP>100</SUB>=[<UP>I</UP>(t)<SUB><UP>−</UP>100</SUB>−<UP>mI</UP><SUB><UP>−</UP>100(1)</SUB>]/[f<SUB><UP>−</UP>100</SUB>(t)−<UP>mI</UP><SUB><UP>−</UP>100(1)</SUB>] (5)
Similarly, in part 3, 
<UP>nI</UP>(t)<SUB><UP>−</UP>40</SUB>=[<UP>I</UP>(t)<SUB><UP>−</UP>40</SUB>−<UP>mI</UP><SUB><UP>−</UP>40(4)</SUB>]/[f<SUB><UP>−</UP>40</SUB>(t)−<UP>mI</UP><SUB><UP>−</UP>40(1)</SUB>] (6)

<UP>nI</UP>(t)<SUB><UP>−</UP>100</SUB>=[<UP>I</UP>(t)<SUB><UP>−</UP>100</SUB>−<UP>mI</UP><SUB><UP>−</UP>100(4)</SUB>]/[f<SUB><UP>−</UP>40</SUB>(t)−<UP>mI</UP><SUB><UP>−</UP>100(1)</SUB>] (7)
where nI(t)-40 and nI(t)-100 are normalized ACh-induced currents at -40 and -100 mV, respectively. We plotted the calculated values against time t in Fig. 4B. Both nI(t)-40 (open circles) and nI(t)-100 (closed circles) gradually decreased to steady-state values within ~40 s after the application of tertiapin. The amplitudes of the normalized currents between 95 and 135 s were 0.60 and 0.64 at -40 and -100 mV, respectively (indicated by lines designated -40 and -100 mV). Thus, tertiapin (10 nM) decreased ACh-induced KACh currents in a similar time course to ~60% independent of the membrane potential.

We also examined whether tertiapin modulated the kinetics of the slow relaxation of KACh channels (Fig. 4C). The trace c - a is the subtraction of trace a from trace c and corresponds to the ACh-induced current at time c. From f-100(t), I(t)-100 would have decreased to 77% at time d if tertiapin had not been applied. Thus, the ACh-induced current at time d in the absence of tertiapin is represented as trace 0.77c - a. The nI(t)-100 indicates that this current further decreased to 64% in the presence of tertiapin (Fig. 4B), which is shown as trace 0.64(0.77c - a) (dotted line). This current trace reasonably overlapped the real ACh-induced current measured at time d (trace d - e, solid line) at -100, -40, and +10 mV. Thus, tertiapin did not change the relaxation kinetics of KACh channels.

By repeating these experiments with different concentrations of tertiapin, we assessed the concentration-dependent effect of tertiapin on KACh channels. Figure 5 summarizes the results. Open and closed circles indicate the averaged values of nI(t)-40 and nI(t)-100, respectively. Bars are S.E. values at each point. No significant difference was found between nI(t)-40 and nI(t)-100 at any concentration of tertiapin. Dotted and solid lines are, respectively, the fit of the data at -40 and -100 mV by the following Hill equation:
<UP>nI</UP>=1/[1+([<UP>tertiapin</UP>]/K<SUB><UP>d</UP></SUB>)<SUP>n</SUP>] (8)
where nI is nI(t)-40 or nI(t)-100, [tertiapin] is the concentration of tertiapin in M, Kd is the dissociation constant in M, and n is the Hill coefficient. Kd and n were estimated as 7.4 nM and 0.81 at -40 mV and as 8.4 nM and 0.82 at -100 mV, respectively. These results indicate that tertiapin inhibited KACh channels in a voltage-independent manner through approximately 1:1 stoichiometry. Squares in the graph represent the data for IK1 channels. These values were obtained as the ratio mI-100(4)/mI-100(1). Tertiapin was at least 100 times less potent in inhibiting IK1 than KACh channels.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Concentration-dependent effect of tertiapin on KACh and IK1 channels. Symbols and bars indicate the mean ± S.E. The number of observation at each point is indicated in parentheses. Open and closed circles indicate the normalized Ach-induced KACh currents at -40 and -100 mV, respectively. Continuous and dotted lines are the fit of the data at -40 and -100 mV by the Hill equation (eq. 8 in text), respectively. The dissociation constant and the Hill coefficient were, respectively, estimated as 7.4 nM and 0.81 at -40 mV and 8.4 nM and 0.82 at -100 mV. Squares represent the IK1 currents at -100 mV in the presence of tertiapin normalized to those in the absence of tertiapin.

Inhibitory Effect of Tertiapin on KACh Channels Is Not Mediated by Muscarinic Receptors. One possible explanation for the selective inhibitory effect of tertiapin on KACh channels might be that tertiapin impaired activation of KACh channels through an antagonistic effect on muscarinic receptors. This possibility is, however, denied in Fig. 6. Here, the whole-cell current was measured in an atrial myocyte with a pipette containing 10 µM GTPgamma S, a hydrolysis-resistant analog of GTP. GTPgamma S can fully activate KACh channels in the absence of any receptor agonists (Ito et al., 1991; Kurachi et al., 1996; Yamada et al., 1998). From the holding potential of -40 mV, the voltage pulse shown in Fig. 4A was applied every 5 s. This current trace started ~2 min after formation of the whole-cell configuration. In this particular experiment, GTPgamma S already activated KACh channels to a stable level from the very beginning of the recording (Fig. 6, A and B, trace a). Tertiapin (100 nM) suppressed the GTPgamma S-induced KACh currents to leave the inactivating IK1 current at -100 mV (Fig. 6B, trace b). Subtraction of the current before the application of tertiapin from that after the application of tertiapin yielded a tertiapin-sensitive current (Fig. 6B, trace a - b). This current exhibited the typical slow relaxation of KACh channels. Similar results were obtained in two other experiments (not shown). Thus, tertiapin inhibited KACh channels in a receptor-independent manner.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of tertiapin on KACh channel currents activated by GTPgamma S. A, a whole-cell current recorded from an atrial myocyte with a pipette containing 3 mM ATP and 10 µM GTPgamma S. The same voltage pulse as in Fig. 4A was applied from -40 mV every 5 s. , current amplitude at the end of the 300-ms voltage step to -100 mV. The inward Na+ current is removed from the trace. This recording started ~2 min after brake-in, at which KACh channels were already activated to a stable level. B, left, current recorded during the single set of voltage pulses at time a (solid line) and b (dotted line) in A. The inward Na+ current is not removed. Right, a tertiapin-sensitive current was obtained by subtracting the trace b from the trace a.

Effect of Tertiapin on KACh Channels at Single-Channel Level. Figure 7A shows the single-channel recordings of KACh channels in the cell-attached configuration with the pipette filled with K+ external solution containing 145 mM KCl and 1 µM ACh with or without 30 nM tertiapin. The cell membrane potential was zeroed by bath perfusion of the internal solution, whereas the patch membrane potential was changed by altering the pipette potential. In the absence of tertiapin (left), numerous brief inward KACh currents appeared at potentials negative to EK (~0 mV under this condition) (Sakmann et al., 1983). At potentials positive to EK, only small outward currents were occasionally seen due to the inward rectification of the channel (Yamada and Kurachi, 1995). In the presence of tertiapin (right), the amplitude of single-channel KACh currents was not significantly different from the control at each membrane potential. Figure 7B depicts the single-channel I-V relationship of KACh channels in the absence (open circles) and presence (closed circles) of 30 nM tertiapin (n = 3 for each point). The linear fit of the averaged data gave the estimate of the single KACh channel conductance of 44.2 pS in the absence of tertiapin (dotted line) and 46.9 pS in the presence of tertiapin (solid line). Thus, tertiapin did not reduce the single-channel conductance of KACh channels.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of tertiapin on the single-channel conductance and open times of KACh channels. A, in the cell-attached configuration, single KACh channel currents of atrial myocytes were recorded at indicated patch membrane potentials. Patch pipettes contained 145 mM K+ and 1 µM ACh with (left) or without (right) 30 nM tertiapin. These two sets of the current traces were obtained from different atrial myocytes. Arrowheads indicate the zero current level in each trace. B, relationship between the membrane potential (Vm) and the single-channel amplitude (i) in the absence (open circle ) and the presence () of 30 nM tertiapin. Symbols and bars indicate the mean ± S.E. of three experiments at each point. Lines are the linear fit of the data in the absence and presence of tertiapin with a slope of 44.2 pS (dotted line) and 46.9 pS (solid line), respectively. C, open-time histograms constructed from experiments shown in A at -80 mV in the absence (top) and presence (bottom) of 30 nM tertiapin. Because the patches were clearly not one-channel patches, the histograms were constructed from the arbitrarily selected portions of the records in which no simultaneous openings of more than one channel were observed. The relative number of events longer than 20 ms is summed in the last bin. The histograms were fit by the following biexponential functions: top graph, y = 0.14 exp(-t/0.6) + 0.029 exp(-t/5.6); bottom graph, y = 0.10 exp(-t/2.0) + 0.0079 exp(-t/10.4), where y is the relative number of events, and t is the open time in ms.

To evaluate a possible effect of tertiapin on single-channel kinetics of KACh channels, we measured the channel open time (Fig. 7C). Reliable assessment of the single-channel kinetics was, however, difficult because multiple KACh channels were always included in single-patch membranes. Therefore, we could estimate the parameter only roughly by constructing open-time histograms from the arbitrarily selected portions of the current records where simultaneous openings of no more than one channel were observed. In the patch membranes shown in A, the open-time histograms could be fit by the biexponential functions with the time constants of 0.6 and 5.6 ms in the control and 2.0 and 10.4 ms in the presence of tertiapin (30 nM). From six independent experiments, these values were, respectively, 0.69 ± 0.05 and 3.88 ± 0.95 ms in the absence of tertiapin (n = 3) and 1.46 ± 0.29 and 5.88 ± 2.29 ms in the presence of 30 nM tertiapin (n = 3) (P = .06 and .46 for the smaller and the larger time constants, respectively). Thus, tertiapin did not significantly affect the open times of KACh channels.

Figure 8A shows the effect of tertiapin on KACh currents in the outside-out configuration. The patch pipette contained the internal solution with 3 mM ATP and 100 µM GTP, whereas the outside of the patch membrane was perfused with the K+ external solution containing indicated agents. The membrane potential was held at -60 mV. ACh (1 µM) strongly induced inward KACh currents, which was substantially inhibited by 100 nM tertiapin. The two left graphs under the trace are the amplitude histograms constructed from parts a and b in the record. In the presence of ACh alone (part a), multiple channels opened simultaneously (top graph). The first obvious four peaks could be fit by gaussian curves (lines), which indicated the single-channel amplitude of -2.05 pA. By dividing the mean current amplitude in part a by this value, the NPo was calculated to be 6.41 (N is the number of functional channels in the patch, and Po is the open probability of each channel). In the presence of ACh and tertiapin (part b), the amplitude histogram exhibited five peaks (bottom graph). Fitting of this histogram by gaussian curves (lines) gave the single-channel amplitude of -1.98 pA. From this value and the mean current amplitude in part b, NPo was calculated as 1.62 in the presence of ACh and tertiapin. Therefore, tertiapin inhibited KACh channels by reducing NPo without changing the single-channel conductance.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of tertiapin on KACh channels in the outside-out and inside-out configurations. A, single-channel recording in the outside-out patch membrane of an atrial myocyte. A patch pipette was filled with the internal solution containing 3 mM ATP and 100 µM GTP. The external side of the patch membrane was perfused with the K+ external solution containing the agents indicated above the current trace. The membrane potential was -60 mV. The two left graphs under the current trace are the amplitude histograms constructed from parts a and b indicated by lines under the current record. The bin width was 0.01 pA. The vertical dotted line indicates the zero current level. The first four peaks in graph a and the first five peaks in graph b were fit by Gaussian curves. The individual Gaussian curves and the sum of them are indicated by lines in the graphs. The estimated single-channel amplitude is indicated in each histogram. The right graph under the current trace shows power density spectra, which were constructed from parts d and e and subtracted with that in the absence of ACh. The lines indicate the fit of the data with the sum of three Lorentzian functions (eq. 1). The corner frequencies were 4.44, 24.6, and 272 Hz in d and 4.97, 30.8, and 241 Hz in e. The corresponding zero-frequency asymptotes were 1.02, 0.258, and 0.00961 pA2s in d and 0.449, 0.0569, and 0.00388 pA2s in e. B, single-channel recording in the inside-out patch membrane of an atrial myocyte. A patch pipette contained the K+ external solution with 1 µM ACh, whereas the internal side of the patch membrane was perfused with the internal solution containing the agents indicated above the trace. The membrane potential was -60 mV. The single-channel amplitude and NPo were measured in the periods indicated by lines under the trace and are shown beneath the lines.

This patch had a relatively high KACh channel activity before the application of ACh (NPo, 0.83 in part c), probably due to the large number of the channels included in the membrane and/or the effect of intracellular ATP on KACh channels in excised membranes (Yamada et al., 1998). After subtracting this basal NPo value from those obtained in parts a and b, we found that tertiapin (100 nM) decreased the ACh-induced KACh channel activity by 85% in this patch and on average by 82 ± 10% in three outside-out patches (not shown). This value was not significantly different from that estimated from the whole-cell experiments (93.5 ± 3.2%, n = 14, Fig. 5).

The right graph under the current trace is the power density spectra constructed from parts d and e in the record. The spectra were individually fit with the sum of three Lorentzian functions (eq. 1). In the absence of tertiapin (part d), the corner frequency of each Lorentzian component was 4.44, 24.6, and 272 Hz, and the corresponding zero-frequency asymptotes were 1.02, 0.258, and 0.00961 pA2s. In the presence of tertiapin (part e), the corner frequencies were 4.97, 30.8, and 241 Hz, and the zero-frequency asymptotes were 0.449, 0.0569, and 0.00388 pA2s, respectively. Table 1 summarizes the averaged data. Neither the corner frequencies nor the relative amplitudes of zero-frequency asymptotes were significantly different in the presence and absence of tertiapin (10 nM). Therefore, tertiapin suppressed KACh currents without significantly affecting the fast single-channel kinetics.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Effect of tertiapin on the power density spectrum of ACh-induced KAch currents

The power density spectra of ACh-induced KAch currents in the cell-attached or outside-out configurations were constructed in the absence and presence of tertiapin (10 nM). The spectra were subtracted with those in the absence of channel openings and then fit with the sum of three Lorentzian functions (eq. 1 in text).

Finally, we examined whether tertiapin could affect KACh channels from the internal side of an inside-out patch membrane (Fig. 8B). The pipette contained the K+ external solution, whereas the internal side of the patch membrane was perfused with the internal solution containing GTPgamma S or tertiapin. The membrane potential was held at -60 mV. KACh channels were irreversibly activated with 10 µM GTPgamma S and then exposed to intracellular tertiapin (100 nM). Tertiapin did not significantly reduce the single-channel amplitude or NPo of KACh channels. Thus, the receptor site for tertiapin resides in the extracellular surface of the channel molecule.

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

We have shown that tertiapin potently suppressed ACh-induced KACh channel currents in rabbit cardiac myocytes (Kd ~ 8 nM) (Figs. 2, 4, and 5). Tertiapin also inhibited IK1 channels, but by only less than 10% at 1 µM (Fig. 5). Thus, tertiapin was at least 100 time more potent in inhibiting KACh than IK1 channels. The other ion channels, including KATP channels, were virtually insensitive to the toxin (Figs. 2 and 3). Tertiapin inhibited KACh channels in a voltage- and receptor-independent manner without affecting the slow relaxation (Figs. 4-6). At the single-channel level, tertiapin reduced NPo without significantly affecting the single-channel conductance or the fast open-closed kinetics (Figs. 7 and 8; Table 1). Therefore, tertiapin is likely to cause a slow block on KACh channels, consistent with the high affinity of the toxin for the channels (Hille, 1992).

Jin and Lu (1998) found that tertiapin selectively blocks certain types of recombinant Kir channels expressed in Xenopus oocytes. Kir channels are formed by four subunits, each of which has two transmembrane segments (Ho et al., 1993; Kubo et al., 1993a; Yang et al., 1995). At least 13 distinct genes for Kir subunits have been identified and classified into six groups according to their primary structure (Kir1.x-Kir6.x; Doupnik et al., 1995). A homotetramer of Kir1.1 (ROMK1) subunits is a weak inward rectifier involved in the electrolyte metabolism in renal tubules but not expressed in the heart (Ho et al., 1993). Kir2.x (IRKx) subunits form as a homotetramer the strong inward rectifier in heart, muscle, and brain (Kubo et al., 1993; Morishige et al., 1994; Takahashi et al., 1994). Kir3.x (GIRKx) subunits make up G protein-gated Kir channels in heart, brain, and endocrine organs by forming either a homotetrameric or heterotetrameric complex (Kubo et al., 1993b; Krapivinsky et al., 1995; Yamada et al., 1998). Tertiapin blocks the homomeric Kir1.1 channel and the heteromeric Kir3.1/Kir3.4 channel with a Kd value of ~2 and ~8 nM, respectively, but blocks Kir2.1 channels by only less than 10% at 1 µM (Jin and Lu, 1998). These results are very consistent with what we found in the present study. The Kir3.1/Kir3.4 channel has been considered the cardiac KACh channel based on biochemical and functional studies (Krapivinsky et al., 1995). The equivalent potency of tertiapin (Kd ~ 8 nM) for the native KACh and the recombinant Kir3.1/Kir3.4 channels strongly supports this hypothesis. IK1 channels were as insensitive to tertiapin as the Kir2.1 channel. However, the native IK1 channel is more similar to the Kir2.2 than the Kir2.1 channel in single-channel conductance and kinetics (Takahashi et al., 1994; Isomoto et al., 1997; Matsumoto et al., 1999). Therefore, the sensitivity of the Kir2.2 channel to tertiapin also must be examined. The cardiac KATP channel is a hetero-octamer composed of four Kir6.2 subunits and four sulfonylurea receptors, ATP-binding cassette protein (Inagaki et al., 1996; Okuyama et al., 1998). The present study indicates that Kir6.2 channels are also insensitive to tertiapin (Fig. 3).

A Kir subunit has a domain referred to as a P or an H5 region between the two transmembrane segments (Kubo et al., 1993a; Isomoto et al., 1997). This region forms a K+ channel pore (Hartmann et al., 1991; Yellen et al., 1991). A site-directed mutagenesis on the P region of Kir1.1 subunit identified amino acids involved in the tertiapin binding (Jin and Lu, 1998). These residues are mainly located both amino and carboxyl terminal to the K+ channel signature sequence that forms the K+ selectivity filter (Heginbotham et al., 1994). A recent crystallographic analysis of the three-dimensional structure of a voltage-dependent K+ channel indicates that these two regions form the turret and the vestibule base, respectively, within the outermost part of the channel pore (Doyle et al., 1998). Although no structural information is available on the tertiapin binding site or sites in the Kir3.1/Kir3.4 channel, what is predicted from the structural analyses agrees with the observed voltage- and receptor-independent effect of extracellular tertiapin (Figs. 5 and 6) and the ineffectiveness of intracellular tertiapin on KACh channels (Fig. 8B). One amino acid (F137) in the P region of Kir3.1 may be responsible for the slow relaxation of KACh channels (Kofuji et al., 1996). The corresponding residue in Kir1.1 subunit (S135) does not significantly contribute to the tertiapin interaction (Jin and Lu, 1998), which is consistent with the lack of the effect of tertiapin on the slow relaxation kinetics (Fig. 4C). Although we could not analyze in detail the single-channel kinetics of KACh channels, tertiapin seems to cause a slow block on the channels (Hille, 1992). The state dependence of the tertiapin block is unknown, but KACh channels do not have to open to interact with tertiapin because KACh channels became refractory to ACh (1 µM) when pretreated with 100 nM tertiapin (not shown). Detailed structural and functional analyses of the interaction of tertiapin and KACh (or Kir3.1/Kir3.4) channels will delineate the pore structure and the mechanism of the gating of the heterotetrameric ion channel.

To summarize, tertiapin potently and specifically blocks KACh channels in cardiac myocytes. Tertiapin can therefore be a powerful pharmacological tool to identify the functional role of KACh channels in the cardiac physiology and pathophysiology.

    Acknowledgments

We are grateful to Dr. Takushi X. Watanabe (Peptide Institute Inc., Osaka, Japan) for technical advice on the handling of tertiapin.

    Footnotes

Accepted for publication December 21, 1999.

Received for publication October 27, 1999.

1 This work was supported by a Research Grant for Cardiovascular Diseases (11C-1) from the Ministry of Health and Welfare of Japan and a grant from Japan Cardiovascular Research Foundation to M. Yamada.

Send reprint requests to: Mitsuhiko Yamada, MD, PhD, Department of Cardiac Physiology, National Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565 Japan. E-mail: yamadacp{at}jsc.ri.ncvc.go.jp

    Abbreviations

Kir, inwardly rectifying K+; KACh, muscarinic K+; NPo, product of the number of functional channels and the open probability of each channel; EK, potassium equilibration potential; KATP, ATP-sensitive K+; GTPgamma S, guanosine 5'-O-(3-thiotriphosphate); ICa, voltage-dependent Ca2+ current: IK, voltage-dependent K+ current; I-V, current-voltage; ACh, acetylcholine.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References